Repare Therapeutics Inc.
A clinical-stage oncology company developing targeted cancer therapies.
RPTX | US
Overview
Corporate Details
- ISIN(s):
- US7602731025
- LEI:
- Country:
- United States of America
- Address:
- 7171 FREDERICK BANTING, SAINT-LAURENT
- Website:
- https://www.reparerx.com/
Description
Repare Therapeutics Inc. is a clinical-stage precision oncology company that develops novel medicines using a proprietary synthetic lethality approach. The company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies. This platform supports a pipeline of product candidates aimed at treating cancers with specific genetic alterations and addressing high unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Repare Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Repare Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Repare Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
